Yeego Connect

Following a thorough safety review, including two meetings of the CDC’s Advisory Committee on Immunization Practices, the U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention have determined that the recommended pause regarding the use of the Janssen (Johnson & Johnson) COVID-19 Vaccine in the U.S. should be lifted and use of the vaccine should resume.

As outlined, the DED’s ARPA plan also includes an additional proposed $25 million for artisans and $100 million for businesses in the new DED “ARPA Navajo Economic Artisan & Business Relief Grant Program 2021.”

The purpose of the grant program is to assist Navajo artisans and businesses facing financial hardship, lost revenue, and/or business interruption due to the COVID-19 public health emergency in order to regain economic stability.

Tribal communities have been quick to vaccinate their populations. That, along with other evidence-backed strategies, were key factors in changing the trajectory for a group that has suffered disproportionately from the coronavirus.